keyword
https://read.qxmd.com/read/38652934/use-of-a-wearable-device-to-compare-subjective-and-objective-fatigue-in-lung-cancer-patients-and-cancer-free-controls
#1
JOURNAL ARTICLE
Ting-Ling Chou, Chi-Huang Shih, Pai-Chien Chou, Jun-Hung Lai, Tsai-Wei Huang
PURPOSE: The study evaluates the use of heart rate variability (HRV), a measure of autonomic nervous system (ANS) modulation via wearable smart bands, to objectively assess cancer-related fatigue (CRF) levels. It aims to enhance understanding of fatigue by distinguishing between LF/HF ratios and LF/HF disorder ratios through HRV and photoplethysmography (PPG), identifying them as potential biomarkers. METHODS: Seventy-one lung cancer patients and 75 non-cancer controls wore smart bands for one week...
April 9, 2024: European Journal of Oncology Nursing: the Official Journal of European Oncology Nursing Society
https://read.qxmd.com/read/38652933/prognostic-value-of-geriatric-8-for-adverse-outcomes-within-30-days-of-surgery-in-older-adults-with-colorectal-cancer-a-retrospective-cohort-study
#2
REVIEW
A M Winters, J Bakker, J Ten Hoor, H J G Bilo, P F Roodbol, M A Edens, E J Finnema
PURPOSE: It is unclear whether the Geriatric-8 (G8) has the accuracy to preselect patients for complete geriatric assessment, and has the ability to predict adverse outcomes in patients with colorectal cancer (CRC). We therefore aimed to determine whether the G8, or other variables present in the medical record, are applicable in predicting 30-day adverse outcomes in older patients undergoing surgery for CRC. METHODS: We performed a retrospective cohort study involving patients ≥70 years who had surgery for CRC between 2018 and 2020 in a general hospital in the Netherlands...
April 16, 2024: European Journal of Oncology Nursing: the Official Journal of European Oncology Nursing Society
https://read.qxmd.com/read/38652878/trans-ancestral-genetic-risk-factors-for-treatment-related-type-2-diabetes-mellitus-in-survivors-of-childhood-cancer
#3
JOURNAL ARTICLE
Cindy Im, Achal Neupane, Jessica L Baedke, Brian Lenny, Angela Delaney, Stephanie B Dixon, Eric J Chow, Sogol Mostoufi-Moab, Tianzhong Yang, Melissa A Richard, M Monica Gramatges, Philip J Lupo, Noha Sharafeldin, Smita Bhatia, Gregory T Armstrong, Melissa M Hudson, Kirsten K Ness, Leslie L Robison, Yutaka Yasui, Carmen L Wilson, Yadav Sapkota
PURPOSE: Type 2 diabetes mellitus (T2D) is a prevalent long-term complication of treatment in survivors of childhood cancer, with marked racial/ethnic differences in burden. In this study, we investigated trans-ancestral genetic risks for treatment-related T2D. PATIENTS AND METHODS: Leveraging whole-genome sequencing data from the St Jude Lifetime Cohort (N = 3,676, 304 clinically ascertained cases), we conducted ancestry-specific genome-wide association studies among survivors of African and European genetic ancestry (AFR and EUR, respectively) followed by trans-ancestry meta-analysis...
April 23, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38652877/datopotamab-deruxtecan-in-advanced-or-metastatic-hr-her2-and-triple-negative-breast-cancer-results-from-the-phase-i-tropion-pantumor01-study
#4
JOURNAL ARTICLE
Aditya Bardia, Ian E Krop, Takahiro Kogawa, Dejan Juric, Anthony W Tolcher, Erika P Hamilton, Toru Mukohara, Aaron Lisberg, Toshio Shimizu, Alexander I Spira, Junji Tsurutani, Senthil Damodaran, Kyriakos P Papadopoulos, Jonathan Greenberg, Fumiaki Kobayashi, Hong Zebger-Gong, Rie Wong, Yui Kawasaki, Tadakatsu Nakamura, Funda Meric-Bernstam
PURPOSE: Datopotamab deruxtecan (Dato-DXd) is an antibody-drug conjugate consisting of a humanized antitrophoblast cell-surface antigen 2 (TROP2) monoclonal antibody linked to a potent, exatecan-derived topoisomerase I inhibitor payload via a plasma-stable, selectively cleavable linker. PATIENTS AND METHODS: TROPION-PanTumor01 (ClinicalTrials.gov identifier: NCT03401385) is a phase I, dose-escalation, and dose-expansion study evaluating Dato-DXd in patients with previously treated solid tumors...
April 23, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38652872/salvage-reirradiation-for-locally-recurrent-prostate-cancer-results-from-a-prospective-study-with-7-2-years-of-follow-up
#5
JOURNAL ARTICLE
Christian Ekanger, Svein Inge Helle, Lars Reisæter, Liv Bolstad Hysing, Rune Kvåle, Alfred Honoré, Karsten Gravdal, Sara Pilskog, Olav Dahl
PURPOSE: There are no well-established re-treatment options for local recurrence after primary curative radiation therapy for prostate cancer (PCa), as prospective studies with long-term follow-up are lacking. Here, we present results from a prospective study on focal salvage reirradiation with external-beam radiation therapy with a median follow-up of 7.2 years. MATERIALS AND METHODS: From 2013 to 2017, 38 patients with biopsy-proven locally recurrent PCa >2 years after previous treatment and absence of grade 2-3 toxicity from the first course of radiation were included...
April 23, 2024: Journal of Clinical Oncology
https://read.qxmd.com/read/38652677/classifying-glioma-via-liquid-biopsy-progress-towards-an-unmet-clinical-need
#6
JOURNAL ARTICLE
Kalil G Abdullah
The diagnosis and classification of glioma by liquid biopsy represents a critical unmet need in neuro oncology. A recent study demonstrates targeted next generation sequencing (NGS) of cell-free DNA (cfDNA) from cerebrospinal fluid (CSF) as an evolving option for liquid biopsy in patients with glioma.
April 23, 2024: Clinical Cancer Research
https://read.qxmd.com/read/38652674/-characteristics-of-radiotherapy-for-adolescents-and-young-adults
#7
REVIEW
L Ollivier, A Laprie, E Jouglar, L Claude, V Martin, X Muracciole, L Padovani, S Supiot, A Escande
Radiotherapy for adolescents and young adults is complex in several aspects. The population is very heterogeneous and has characteristics derived from both paediatric and adult populations both in terms of pathology (anatomical pathology, response to treatment) and the patient's physical, biological and psychological characteristics. This article reviews the characteristics to be taken into account in adolescent and young adult patients radiotherapy and more particularly in some of the most common diseases.
December 2023: Cancer Radiothérapie: Journal de la Société Française de Radiothérapie Oncologique
https://read.qxmd.com/read/38652646/psychosocial-distress-screening-among-interprofessional-palliative-care-teams-a-narrative-review
#8
JOURNAL ARTICLE
Chelsea K Brown, Cara L Wallace
With increased need for palliative care and limited staffing resources, non-social workers are increasingly responsible for screening for urgent psychosocial distress. The National Consensus Project guidelines call for all palliative care team members to be competent in screening across domains. Yet, in contrast to an abundance of evidence-informed tools for palliative social work assessments, standardization for interprofessional psychosocial screening is lacking. This lack of standardized practice may lead to harmful disparities in care delivery...
April 23, 2024: Journal of Social Work in End-of-life & Palliative Care
https://read.qxmd.com/read/38652565/renal-cell-carcinoma-histologic-subtypes-exhibit-distinct-transcriptional-profiles
#9
JOURNAL ARTICLE
Pedro Barata, Shuchi Gulati, Andrew Elliott, Hans J Hammers, Earle F Burgess, Benjamin A Gartrell, Sourat Darabi, Mehmet A Bilen, Arnab Basu, Daniel M Geynisman, Nancy A Dawson, Matthew R Zibelman, Tian Zhang, Shuanzeng Wei, Charles J Ryan, Elisabeth I Heath, Kelsey A Poorman, Chadi Nabhan, Rana R McKay
Molecular profiling of clear cell RCC (ccRCC) tumors of clinical trial patients has identified distinct transcriptomic signatures with predictive value, yet data in non-clear cell variants (nccRCC) are lacking. We examined the transcriptional profiles of RCC tumors representing key molecular pathways, from a multi-institutional, real-world patient cohort, including ccRCC (n = 508) and centrally-reviewed nccRCC (n = 149) samples. ccRCC had increased angiogenesis signature scores compared to the heterogeneous group of nccRCC tumors (mean z-score 0...
April 23, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38652550/human-nlrc4-promotes-cancer-survival-and-is-associated-to-type-i-interferon-signaling-and-immune-infiltration
#10
JOURNAL ARTICLE
Charlotte Domblides, Steven Crampton, Hong Liu, Juliet M Bartleson, Annie Nguyen, Claudia Champagne, Emily E Landy, Lindsey Spiker, Christopher Proffitt, Sunil Bhattarai, Anissa P Grawe, Matias Fuentealba Valenzuela, Lydia Lartigue, Isabelle Mahouche, Jeremy Dupaul-Chicoine, Kazuho Nishimura, Félix Lefort, Marie Decraecker, Valérie Velasco, Sonia Netzer, Vincent Pitard, Christian Roy, Isabelle Soubeyran, Victor Racine, Patrick Blanco, Julie Déchanet-Merville, Maya Saleh, Scott W Canna, David Furman, Benjamin Faustin
The immune system can control cancer progression. However, even though some innate immune sensors of cellular stress are expressed intrinsically in epithelial cells, their potential role in cancer aggressiveness and subsequent overall survival in humans is mainly unknown. Here, we show that NLR family CARD Domain Containing 4 (NLRC4) is downregulated in epithelial tumor cells of colorectal cancer (CRC) patients by using spatial tissue imaging. Strikingly, only the loss of tumor NLRC4 but not stromal is associated with poor immune infiltration (mainly dendritic and CD4+/CD8+ T cells) and accurately predicts progression to metastatic Stage IV and decrease of overall survival...
April 23, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38652549/oncogene-induced-matrix-reorganization-controls-cd8-t-cell-function-in-the-soft-tissue-sarcoma-microenvironment
#11
JOURNAL ARTICLE
Ashley M Fuller, Hawley C Pruitt, Ying Liu, Valerie M Irizarry-Negron, Hehai Pan, Hoogeun Song, Ann DeVine, Rohan S Katti, Samir Devalaraja, Gabrielle E Ciotti, Michael V Gonzalez, Erik F Williams, Ileana Murazzi, Dimitris Ntekoumes, Nicolas Skuli, Hakon Hakonarson, Daniel J Zabransky, Jose G Trevino, Ashani Weeraratna, Kristy Weber, Malay Haldar, Joseph A Fraietta, Sharon Gerecht, T S Karin Eisinger-Mathason
CD8+ T cell dysfunction impedes anti-tumor immunity in solid cancers but the underlying mechanisms are diverse and poorly understood. Extracellular matrix (ECM) composition has been linked to impaired T cell migration and enhanced tumor progression; however, impacts of individual ECM molecules on T cell function in the tumor microenvironment (TME) are only beginning to be elucidated. Upstream regulators of aberrant ECM deposition and organization in solid tumors are equally ill-defined. Therefore, we investigated how ECM composition modulates CD8+ T cell function in undifferentiated pleomorphic sarcoma (UPS), an immunologically active desmoplastic tumor...
April 23, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38652547/multi-omics-characterization-of-esophageal-squamous-cell-carcinoma-identifies-molecular-subtypes-and-therapeutic-targets
#12
JOURNAL ARTICLE
Dengyun Zhao, Yaping Guo, Huifang Wei, Xuechao Jia, Yafei Zhi, Guiliang He, Wenna Nie, Limeng Huang, Penglei Wang, Kyle Vaughn Laster, Zhicai Liu, Jinwu Wang, Mee-Hyun Lee, Zigang Dong, Kangdong Liu
Esophageal squamous cell carcinoma (ESCC) is the predominant form of esophageal cancer and is characterized by an unfavorable prognosis. To elucidate the distinct molecular alterations in ESCC and investigate therapeutic targets, we performed a comprehensive analysis of transcriptomic, proteomic, and phosphoproteomic data derived from 60 paired treatment-naive ESCC and adjacent non-tumor tissue samples. Additionally, we conducted a correlation analysis to describe the regulatory relationship between transcriptomic and proteomic processes, revealing alterations in key metabolic pathways...
April 23, 2024: JCI Insight
https://read.qxmd.com/read/38652475/cdh1-genotype-exploration-in-women-with-hereditary-lobular-breast-cancer-phenotype
#13
JOURNAL ARTICLE
Giovanni Corso, Elena Marino, Cristina Zanzottera, Carla Oliveira, Loris Bernard, Debora Macis, Joana Figueiredo, Joana Pereira, Patrícia Carneiro, Giulia Massari, Massimo Barberis, Alessandra Margherita De Scalzi, Sergio Vincenzo Taormina, Elham Sajjadi, Claudia Sangalli, Sara Gandini, Oriana D'Ecclesiis, Cristina Maria Trovato, Anna Rotili, Filippo Pesapane, Luca Nicosia, Carlo La Vecchia, Viviana Galimberti, Elena Guerini-Rocco, Bernardo Bonanni, Paolo Veronesi
IMPORTANCE: Pathogenic or likely pathogenic (P/LP) germline CDH1 variants are associated with risk for diffuse gastric cancer and lobular breast cancer (LBC) in the so-called hereditary diffuse gastric cancer (HDGC) syndrome. However, in some circumstances, LBC can be the first manifestation of this syndrome in the absence of diffuse gastric cancer manifestation. OBJECTIVES: To evaluate the frequency of germline CDH1 variants in women with the hereditary LBC (HLBC) phenotype, somatic CDH1 gene inactivation in germline CDH1 variant carriers' tumor samples, and the association of genetic profiles with clinical-pathological data and survival...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38652459/telemedicine-in-geriatric-oncology-lessons-learned-from-the-covid-19-experience
#14
JOURNAL ARTICLE
Leana Cabrera Chien, Carolina Uranga, Vani Katheria
PURPOSE OF REVIEW: Telemedicine quickly became integrated into healthcare caused by the Coronavirus 19 (COVID-19) pandemic. Rapid use of telemedicine into healthcare systems was supported by the World Health Organization and other prominent national organizations to reduce transmission of the virus while continuing to provide access to care. In this review, we explored the effect of this swift change in care and its impact on older adults with cancer. RECENT FINDINGS: Older adults are susceptible to the COVID-19 virus caused by various risk factors, such as comorbidity, frailty, decreased immunity, and cancer increases vulnerability to infection, hospitalization, and mortality...
April 23, 2024: Current Opinion in Supportive and Palliative Care
https://read.qxmd.com/read/38652434/short-and-long-term-post-nephrectomy-outcomes-for-retroperitoneal-liposarcoma-from-a-high-volume-sarcoma-center-a-propensity-score-matching-analysis
#15
JOURNAL ARTICLE
Guoqiang Xue, Zhen Wang, Bonan Liu, Chengpeng Li, Ang Lv, Xiuyun Tian, Jianhui Wu, Hui Qiu, Chunyi Hao
BACKGROUND: Multivisceral en bloc resection with the ipsilateral kidney is commonly performed in patients with retroperitoneal liposarcoma (RLPS). We evaluated the effect of nephrectomy on short- and long-term outcomes in patients with RLPS. METHODS: Data from a prospectively maintained database of the Peking University Cancer Hospital Sarcoma Center between April 2011 and August 2022 were analyzed. We classified the RLPS patients who underwent surgery into nephrectomy group (NP) and non-nephrectomy group (non-NP)...
April 23, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38652431/cancer-related-health-and-educational-needs-and-faith-based-health-beliefs-in-an-urban-muslim-population
#16
JOURNAL ARTICLE
Aisha Choudhri, Lucile Adams-Campbell, Mireille Bright, Jialing Zhu, Chiranjeev Dash
Cancer screening behaviors in Muslims are under-researched, and there is limited data on how it relates to their unique cultural and religious beliefs. We assessed cancer prevention and screening-related health needs in the Washington DC area. We developed the needs assessment questionnaires and recruitment strategy in collaboration with key faith leaders from four mosques in our catchment area. A total of 203 participants were recruited through community outreach and engagement approaches and were included in the discussion when developing the needs assessment to ensure questions were religiously and culturally sensitive...
April 23, 2024: Journal of Cancer Education: the Official Journal of the American Association for Cancer Education
https://read.qxmd.com/read/38652426/antibody-drug-conjugates-in-urological-cancers-a-review-of-the-current-landscape
#17
REVIEW
Aruni Ghose, Patricia Lapitan, Vedika Apte, Adheesh Ghosh, Abhinav Kandala, Sreejana Basu, Jo Parkes, Sayali D Shinde, Stergios Boussios, Anand Sharma, Prantik Das, Nikhil Vasdev, Sara E Rebuzzi, Yüksel Ürün, Ravindran Kanesvaran, Akash Maniam, Giuseppe L Banna
PURPOSE OF REVIEW: Our review delves into the progress across urological malignancies and discusses ongoing challenges and future directions in antibody-drug conjugate (ADC) development, emphasising their transformative potential in cancer care. RECENT FINDINGS: ADCs have advanced from hematologic to solid tumours, notably in breast cancer, and are now pivotal in metastatic urological cancers as both monotherapies and in combination regimens, underscored by the FDA's approval of enfortumab vedotin and sacituzumab govitecan for metastatic urothelial cancer...
April 23, 2024: Current Oncology Reports
https://read.qxmd.com/read/38652425/navigating-breast-cancer-oligometastasis-and-oligoprogression-current-landscape-and-future-directions
#18
REVIEW
Stephanie M Yoon, Jose G Bazan
PURPOSE: We examine the potential for curative approaches among metastatic breast cancer (MBC) patients by exploring the recent literature on local ablative therapies like surgery and stereotactic body radiation therapy (SBRT) in patients with oligometastatic (OM) breast cancer. We also cover therapies for MBC patients with oligoprogressive (OP) disease. KEY FINDINGS: Surgery and SBRT have been studied for OM and OP breast cancer, mainly in retrospective or non-randomized trials...
April 23, 2024: Current Oncology Reports
https://read.qxmd.com/read/38652424/the-growing-role-of-digital-health-tools-in-the-care-of-patients-with-cancer-current-use-future-opportunities-and-barriers-to-effective-implementation
#19
REVIEW
Robert Haemmerle, Jonas Paludo, Tufia C Haddad, Joshua C Pritchett
PURPOSE OF REVIEW: This article aims to describe the ways in which digital health technologies are currently being used to improve the delivery of cancer care, highlight opportunities to expand their use, and discuss barriers to effective and equitable implementation. RECENT FINDINGS: The utilization of digital health tools and development of novel care delivery models that leverage such tools is expanding. Recent studies have shown feasibility and increased implementation in the setting of oncologic care...
April 23, 2024: Current Oncology Reports
https://read.qxmd.com/read/38652406/ferroptosis-is-an-effective-strategy-for-cancer-therapy
#20
REVIEW
Afrasyab Khan, Yu Huo, Yilei Guo, Juanjuan Shi, Yongzhong Hou
Ferroptosis is a form of intracellular iron-dependent cell death that differs from necrosis, autophagy and apoptosis. Intracellular iron mediates Fenton reaction resulting in lipid peroxidation production, which in turn promotes cell death. Although cancer cell exhibit's ability to escape ferroptosis by multiple pathways such as SLC7A11, GPX4, induction of ferroptosis could inhibit cancer cell proliferation, migration and invasion. In tumor microenvironment, ferroptosis could affect immune cell (T cells, macrophages etc...
April 23, 2024: Medical Oncology
keyword
keyword
516
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.